The NHS Business Services Authority (NHSBSA) has updated their antibiotic review spreadsheet for the Pharmacy Quality Scheme (PQS) 2022/23.
As part of the Prevention domain, contractors are required to carry out a TARGET leaflet review (further details of the requirements can be found on the PSNC PQS hub page under the ‘Domain 4 – Prevention’ section) and report the data collected on the NHSBSA MYS data collection tool by the end of 31st March 2023.
On the spreadsheet, contractors have been allocated a colour:
Green: These contractors have added data for 30 patients and have submitted their data. No further action is required by these contractors to meet this quality criterion.
Orange: These contractors have added data for fewer than 30 patients (or have not identified any patients for the review over a eight week period) and have submitted their data. This may be correct if contractors have carried out the audit for eight weeks (if the minimum number of patients is not achieved within four weeks, contractors are required to complete this over eight weeks) and have still not been able to speak to 15 patients for each leaflet. Therefore they may have added the data for the patients they did speak to during this period (or ticked the box to indicate that there is no patient data to add) and submitted this.
However, PSNC has been made aware that several contractors have mistakenly submitted their data before they had entered all their patient data. Therefore, contractors that are showing as orange are advised to check their data number is correct and if not, email the NHSBSA Provider Assurance Team on email@example.com for further support as soon as possible.
Red: These contractors have either not started the audit or have started it but have not yet submitted their data to NHSBSA.
The spreadsheet is correct as of 27th March 2023.
Contractors are also reminded that if they have conducted the audit over eight weeks but did not identify any patients for the review, they are still required to declare that no patients were identified as being suitable for review on the antibiotic review data collection tool on MYS by the end of 31st March 2023.
Further information on both of these criteria can be found on the PSNC PQS hub page.